Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age

Journal of the American College of Cardiology

Volumn 33, Issue 1, 1999, Pages 157-163

  Gazzaruso, Carmine ^a,b   Garzaniti, Adriana ^a   Buscaglia, Paola ^a   Bonetti, Graziella ^a   Falcone, Colomba ^a   Fratino, Pietro ^a   Finardi, Giorgio ^a   Geroldi, Diego ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; CHOLESTEROL; HEART ENZYME; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; GENETIC RISK; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0032904484     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00541-5     Document Type: Article

References (44)

1. Scanu AM, Fless GM. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest 1990;85:1709-15.
2. Ilyas Kamboh M, Ferrel RE, Kottke BA. Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet 1991;49:1063-74.
3. Marcovina SM, Zhang ZH, Gaur VP, Albers JJ. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun 1993;191:1192-6.
4. Boerwinkle E, Leffert CC, Lin C, Lackner G, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentration. J Clin Invest 1992;90:52-60.
5. Sunayama S, Daida H, Mokuno H, et al. Lack of increased atherosclerotic risk due to elevated lipoprotein(a) in women ≥55 years of age. Circulation 1996;94:1263-8.
6. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein(a), plasma lipid and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758-65.
7. Rhoads JJ, Dahlen GH, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256:2540-4.
8. Sandkamp M, Funke H, Schulte H, Kolher E, Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990;36:20-3.
9. Bostom AG, Cupples LA, Jenner JL, et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA 1996;276:544-8.
10. Genest J, Jenner JL, McNamara JR, et al. Prevalence of lipoprotein(a) [Lp(a)] excess in coronary artery disease. Am J Cardiol 1991;67:1039-45.
11. Rosengren A, Wihelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ 1990;301:1248-51.
12. Durrington PN, Ishola M, Hunt L, Arrol S, Bhatnagar D. Apolipoproteins(a), A1, and B and parental history in men with early onset ischemic heart disease. Lancet 1988;ii:1070-3.
13. Simons L, Friedlander Y, Simons J, McCallum J. Lipoprotein(a) is not associated with coronary heart disease in the elderly: a cross-sectional data from the Dubbo study. Atherosclerosis 1993;99:87-95.
14. Kario K, Matsuo T, Imiya M, et al. Close relation between lipoprotein(a) levels and atherothrombotic disease in Japanese subjects >75 years of age. Am J Cardiol 1994;73:1187-90.
15. Seed M, Hoppichler F, Reaveley D, et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990;322:1494-9.
16. Sandholzer C, Saha N, Kark JD, et al. Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb 1992;12:1214-26.
17. Parlavecchia M, Pancaldi A, Taramelli R, et al. Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men <55 years of age. Am J Cardiol 1994;74:346-51.
18. Kraft HG, Lingenhel A, Kochl S, et al. Apolipoprotein(a) Kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vase Biol 1996;16:713-9.
19. Gazzaruso C, Buscaglia P, Garzaniti A, et al. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension. J Hypertens 1997;15:227-35.
20. Gazzaruso C, Garzaniti A, Buscaglia P, et al. Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism. J Cardiovasc Risk 1998;5:37-42.
21. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
22. 1993 Guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting. ISH Hypertension News Special Edition, June 1993:3-16.
23. Falcone C, De Servi S, Poma E, et al. Clinical significance of exercise-induced silent myocardial ischaemia in patients with coronary artery disease. J Am Coll Cardiol 1987;9:295-9.
24. Friedewald WT, Levy RI, Fredrikson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without ultracentrifuge. Clin Chem 1972;18:499-502.
25. Li KM, Wilcken DEL, Dudman NPB. Effect of serum lipoprotein(a) on estimation of low density lipoprotein cholesterol by the Friedewald formula. Clin Chem 1994;40:571-3.
26. Geroldi D, Bellotti V, Buscaglia P, et al. Characterization of apo(a) polymorphism by a modified immunoblotting technique in an Italian population sample. Clin Chim Acta 1993;221:159-69.
27. Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest 1992;89:1040-6.
28. Gazzaruso C, Buscaglia P, Garzaniti A, et al. Lp(a) plasma concentrations, apo(a) apolipoprotein(a), polymorphism and family history of coronary heart disease in patients with essential hypertension. J Cardiovasc Risk 1996;3:191-7.
29. Buscaglia P, Gazzaruso C, Garzaniti A, Bonetti G, Fratino P, Geroldi D. Lipoprotein(a), apolipoprotein(a), polymorphism and insulin treatment in type 2 diabetic patients (letter). Diabetes Care 1995;18:1202-3.
30. Gazzaruso C, Bonetti G, Garzaniti A, et al. Increased plasma concentrations of lipoprotein(a) for every phenotype of apolipoprotein(a) in patients with chronic renal failure treated by hemodialysis. Nutr Metab Cardiovasc Dis 1996;6:203-10.
31. Kikuchi S, Nakagawa A, Kobayashi K, et al. High degree of genetic polymorphism in apolipoprotein(a) associated with plasma lipoprotein(a) levels in Japanese and Chinese populations. Hum Genet 1993;92:537-44.
32. Schaefer EJ, Lamon-Fava S, Jenner JL, et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid research clinics coronary primary prevention trial. JAMA 1994;27:999-1003.
33. Sigurdsson G, Baldursdottir A, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfusson N. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol 1992;69:1251-4.
34. Cremer P, Nagel D, Labrot B, et al. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 1994;24:444-53.
35. Jauhianen M, Koskinen P, Ehnolm C, et al. Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991;85:59-67.
36. Alfthan G, Pekkanen J, Jauhainen M, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994;106:9-19.
37. Cantin B, Gagnon F, Moorjani S, et al. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. J Am Coll Cardiol 1998;31:519-25.
38. Wild SH, Fortmann SP, Marcovina SM. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project Participants. Arterioscler Thromb Vase Biol 1997;17:239-45.
39. Perombelon YFN, Soutar AK, Knight B. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J Clin Invest 1994;93:1481-92.
40. Boerwinkle E. Genetics of plasma lipoprotein(a) concentrations. Curr Opin Lipidol 1992;3:128-36.
41. Marcovina SM, Albers JJ, Wijsman E, Zhang ZH, Chapman NH, Kennedy H. Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res 1996;37:2569-85.
42. Liu AC, Lawn RM. Vascular interaction of lipoprotein(a). Curr Opin Lipidol 1994;5:269-73.
43. Kang C, Durlach V, Soulat T, Fournier C, Angles-Cano F. Lipoprotein(a) isoforms display differences in affinity for plasminogen-like binding to human mononuclear cells. Arterioscler Thromb Vase Biol 1997;17:2036-43.
44. Simon DI, Ezratty AM, Loscalzo J. Lipoprotein(a) and atherothrombosis. Curr Opin Cardiol 1993;8:814-20.